JP2022545259A5 - - Google Patents
Info
- Publication number
- JP2022545259A5 JP2022545259A5 JP2022511238A JP2022511238A JP2022545259A5 JP 2022545259 A5 JP2022545259 A5 JP 2022545259A5 JP 2022511238 A JP2022511238 A JP 2022511238A JP 2022511238 A JP2022511238 A JP 2022511238A JP 2022545259 A5 JP2022545259 A5 JP 2022545259A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962893799P | 2019-08-29 | 2019-08-29 | |
| US62/893,799 | 2019-08-29 | ||
| US201962894526P | 2019-08-30 | 2019-08-30 | |
| US62/894,526 | 2019-08-30 | ||
| PCT/US2020/048618 WO2021041972A1 (en) | 2019-08-29 | 2020-08-28 | Anti-il31 antibodies for veterinary use |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022545259A JP2022545259A (ja) | 2022-10-26 |
| JPWO2021041972A5 JPWO2021041972A5 (https=) | 2023-09-04 |
| JP2022545259A5 true JP2022545259A5 (https=) | 2023-09-04 |
| JP7671275B2 JP7671275B2 (ja) | 2025-05-01 |
Family
ID=74686094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022511238A Active JP7671275B2 (ja) | 2019-08-29 | 2020-08-28 | 動物用の抗ｉｌ３１抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220324960A1 (https=) |
| EP (1) | EP4021499A4 (https=) |
| JP (1) | JP7671275B2 (https=) |
| KR (1) | KR20220071191A (https=) |
| CN (1) | CN114555121A (https=) |
| AU (1) | AU2020336210A1 (https=) |
| BR (1) | BR112022002771A2 (https=) |
| CA (1) | CA3147809A1 (https=) |
| MX (1) | MX2022002360A (https=) |
| WO (1) | WO2021041972A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102460040B1 (ko) | 2016-04-27 | 2022-11-01 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| WO2018156180A1 (en) | 2017-02-24 | 2018-08-30 | Kindred Biosciences, Inc. | Anti-il31 antibodies for veterinary use |
| CN114989299B (zh) * | 2022-06-21 | 2023-05-26 | 北京索莱宝科技有限公司 | 一种单克隆抗体的组合物及其应用、检测人白细胞介素1β的试剂、试剂盒和方法 |
| CN117186220A (zh) * | 2023-07-20 | 2023-12-08 | 北京伟杰信生物科技有限公司 | 可结合白介素31的抗体或其抗原结合片段及其制备方法和应用 |
| CN120865402A (zh) * | 2023-11-27 | 2025-10-31 | 宁波贝安生物科技有限公司 | 抗il-31的抗体及其用途 |
| CN121108334A (zh) * | 2024-06-11 | 2025-12-12 | 优迈生物科技(连云港)有限公司 | 抗犬il-31的抗体及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE335072T1 (de) * | 1993-05-28 | 2006-08-15 | Scripps Research Inst | Methoden für inhibition der cd14-abhängigen zellaktivierung |
| US7084257B2 (en) * | 2001-10-05 | 2006-08-01 | Amgen Inc. | Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
| EP1485126A4 (en) * | 2001-12-21 | 2007-03-21 | Idexx Lab Inc | DOG IMMUNOGLOBULIN VARIABLE DOMAINS, DOG ANTIBODIES, AND METHOD FOR THEIR PRODUCTION AND USE |
| CN102321174B (zh) * | 2005-05-06 | 2013-10-16 | 津莫吉尼蒂克斯公司 | Il-31单克隆抗体及使用方法 |
| DK2594586T3 (en) * | 2006-09-01 | 2014-11-17 | Zymogenetics Inc | Monoclonal il-31 antibodies and methods of use thereof |
| GB2504887B (en) * | 2011-05-06 | 2016-02-03 | Nvip Pty Ltd | Anti-Nerve growth factor antibodies and methods of preparing and using the same |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| HK1201281A1 (en) * | 2011-10-13 | 2015-08-28 | Nexvet Australia Pty Ltd | Canine/feline cd20 binding epitope and compositions for binding thereto |
| CA2886161A1 (en) * | 2012-09-29 | 2014-04-03 | The Trustees Of The University Of Pennsylvania | Veterinary composition and methods for non-surgical neutering and castration |
| US9499621B2 (en) * | 2013-04-08 | 2016-11-22 | Cytodyn, Inc. | Felinized antibodies and methods of treating retroviral infections in felines |
| CN103965357B (zh) * | 2013-12-31 | 2016-08-17 | 嘉和生物药业有限公司 | 一种抗人rankl抗体 |
| KR20170134748A (ko) * | 2015-04-14 | 2017-12-06 | 추가이 세이야쿠 가부시키가이샤 | Il-31 안타고니스트를 유효 성분으로서 함유하는 아토피성 피부염의 예방용 및/또는 치료용 의약 조성물 |
| CN109789201B (zh) * | 2016-04-15 | 2023-06-16 | 伊穆奈克斯特股份有限公司 | 抗人vista抗体及其用途 |
| WO2017192589A1 (en) * | 2016-05-02 | 2017-11-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Neutralizing antibodies to influenza ha and their use and identification |
| WO2018156180A1 (en) * | 2017-02-24 | 2018-08-30 | Kindred Biosciences, Inc. | Anti-il31 antibodies for veterinary use |
| MX2020006105A (es) * | 2017-12-11 | 2020-11-09 | Ubi Ip Holdings | Inmunógenos peptídicos de il-31 y formulaciones de estos para el tratamiento y/o la prevención de la dermatitis atópica. |
| WO2020056393A1 (en) * | 2018-09-14 | 2020-03-19 | Kindred Biosciences, Inc. | Anti-il4 receptor antibodies for veterinary use |
-
2020
- 2020-08-28 CA CA3147809A patent/CA3147809A1/en active Pending
- 2020-08-28 BR BR112022002771A patent/BR112022002771A2/pt unknown
- 2020-08-28 KR KR1020227009547A patent/KR20220071191A/ko not_active Ceased
- 2020-08-28 EP EP20858503.4A patent/EP4021499A4/en active Pending
- 2020-08-28 AU AU2020336210A patent/AU2020336210A1/en active Pending
- 2020-08-28 JP JP2022511238A patent/JP7671275B2/ja active Active
- 2020-08-28 MX MX2022002360A patent/MX2022002360A/es unknown
- 2020-08-28 WO PCT/US2020/048618 patent/WO2021041972A1/en not_active Ceased
- 2020-08-28 US US17/638,372 patent/US20220324960A1/en active Pending
- 2020-08-28 CN CN202080073011.6A patent/CN114555121A/zh active Pending